Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 6693

BillFederalHouseIn Committee
Lung Cancer Screening and Prevention Act of 2023
About This Bill
Committee
Latest Action · December 17, 2024
Referred to the Subcommittee on Health.
Congress
118th (2023–2025)
Introduced
December 11, 2023
Cosponsors (5)
1D 4R
View PDF ↗

Summary

Highlight any text to annotate
This bill amends Medicare law to expand coverage of lung cancer screening tests beyond those currently covered. Under current rules, Medicare covers only certain screening tests for early lung cancer detection, but this legislation authorizes the Secretary of Health and Human Services to approve coverage of additional FDA-cleared or FDA-approved lung cancer screening tests as preventive services. The bill directs the Secretary to determine which patients are appropriate for these new screening tests and set the frequency and payment limits for coverage. The Secretary must use Medicare's standard national coverage determination process when deciding whether to cover new lung cancer screening tests, though the bill simplifies this process by removing certain requirements. The changes take effect immediately upon enactment and apply to preventive services covered under Medicare Part B.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.